Insider · CIK 0001786304

Evans John M.

Reports to the SEC for 2 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001786304

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-16	BEAMBeam Therapeutics Inc.M Exercise/Conversion	Director, CEO	MExercise/Conversion	+25K sh	$1.03	+$25.8K	1,072,205
2026-10-16	BEAMBeam Therapeutics Inc.S Sale	Director, CEO	SSale	−25K sh	$23.98	−$600K	1,047,205
2026-10-16	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CEO	MExercise/Conversion	−25K sh	—	—	155,804
2026-10-15	BEAMBeam Therapeutics Inc.M Exercise/Conversion	Director, CEO	MExercise/Conversion	+25K sh	$1.03	+$25.8K	1,072,205
2026-10-15	BEAMBeam Therapeutics Inc.S Sale	Director, CEO	SSale	−25K sh	$23.57	−$589K	1,047,205
2026-10-15	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CEO	MExercise/Conversion	−25K sh	—	—	180,804
2026-06-30	BEAMBeam Therapeutics Inc.M Exercise/Conversion	Director, CEO	MExercise/Conversion	+25K sh	$1.03	+$25.8K	1,072,205
2026-06-30	BEAMBeam Therapeutics Inc.S Sale	Director, CEO	SSale	−23.1K sh	$34.26	−$791K	1,049,105
2026-06-30	BEAMBeam Therapeutics Inc.S Sale	Director, CEO	SSale	−1,900 sh	$34.84	−$66.2K	1,047,205
2026-06-30	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CEO	MExercise/Conversion	−25K sh	—	—	205,804
2026-06-29	BEAMBeam Therapeutics Inc.M Exercise/Conversion	Director, CEO	MExercise/Conversion	+18.7K sh	$0.67	+$12.5K	1,065,868
2026-06-29	BEAMBeam Therapeutics Inc.M Exercise/Conversion	Director, CEO	MExercise/Conversion	+6,337 sh	$1.03	+$6,527.11	1,072,205
2026-06-29	BEAMBeam Therapeutics Inc.S Sale	Director, CEO	SSale	−13.4K sh	$35.13	−$472K	1,058,784
2026-06-29	BEAMBeam Therapeutics Inc.S Sale	Director, CEO	SSale	−11.6K sh	$35.91	−$416K	1,047,205
2026-06-29	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CEO	MExercise/Conversion	−18.7K sh	—	—	9
2026-06-29	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CEO	MExercise/Conversion	−6,337 sh	—	—	230,804
2026-04-01	BEAMBeam Therapeutics Inc.S Sale	Director, CEO	SSale	−30.1K sh	$24.58	−$739K	1,047,205
2026-03-31	BEAMBeam Therapeutics Inc.M Exercise/Conversion	Director, CEO	MExercise/Conversion	+25K sh	$0.67	+$16.8K	1,011,667
2026-03-31	BEAMBeam Therapeutics Inc.S Sale	Director, CEO	SSale	−25K sh	$22.76	−$569K	986,667
2026-03-31	BEAMBeam Therapeutics Inc.A Award	Director, CEO	AAward	+90K sh	—	—	1,076,667
2026-03-31	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CEO	MExercise/Conversion	−25K sh	—	—	18,672
2026-03-30	BEAMBeam Therapeutics Inc.M Exercise/Conversion	Director, CEO	MExercise/Conversion	+25K sh	$0.67	+$16.8K	1,011,667
2026-03-30	BEAMBeam Therapeutics Inc.S Sale	Director, CEO	SSale	−25K sh	$22.37	−$559K	986,667
2026-03-30	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CEO	MExercise/Conversion	−25K sh	—	—	43,672
2026-01-31	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award	Director, CEO	AAward	+180K sh	—	—	180,000
2026-01-30	BEAMBeam Therapeutics Inc.M Exercise/Conversion	Director, CEO	MExercise/Conversion	+25K sh	$0.67	+$16.8K	1,011,667
2026-01-30	BEAMBeam Therapeutics Inc.S Sale	Director, CEO	SSale	−22.1K sh	$28.27	−$625K	989,573
2026-01-30	BEAMBeam Therapeutics Inc.S Sale	Director, CEO	SSale	−2,906 sh	$29.00	−$84.3K	986,667
2026-01-30	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CEO	MExercise/Conversion	−25K sh	—	—	68,672
2026-01-29	BEAMBeam Therapeutics Inc.M Exercise/Conversion	Director, CEO	MExercise/Conversion	+19.3K sh	$0.67	+$13K	1,006,003
2026-01-29	BEAMBeam Therapeutics Inc.M Exercise/Conversion	Director, CEO	MExercise/Conversion	+5,664 sh	$0.67	+$3,794.88	1,011,667
2026-01-29	BEAMBeam Therapeutics Inc.S Sale	Director, CEO	SSale	−16.3K sh	$29.19	−$477K	995,334
2026-01-29	BEAMBeam Therapeutics Inc.S Sale	Director, CEO	SSale	−8,667 sh	$29.74	−$258K	986,667
2026-01-29	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CEO	MExercise/Conversion	−19.3K sh	—	—	0
2026-01-29	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CEO	MExercise/Conversion	−5,664 sh	—	—	93,672
2025-10-02	BEAMBeam Therapeutics Inc.M Exercise/Conversion	Director, CEO	MExercise/Conversion	+25K sh	$0.67	+$16.8K	1,011,667
2025-10-02	BEAMBeam Therapeutics Inc.S Sale	Director, CEO	SSale	−25K sh	$24.63	−$616K	986,667
2025-10-02	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CEO	MExercise/Conversion	−25K sh	—	—	19,336
2025-10-01	BEAMBeam Therapeutics Inc.M Exercise/Conversion	Director, CEO	MExercise/Conversion	+25K sh	$0.67	+$16.8K	1,011,667
2025-10-01	BEAMBeam Therapeutics Inc.S Sale	Director, CEO	SSale	−25K sh	$24.51	−$613K	986,667
2025-10-01	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CEO	MExercise/Conversion	−25K sh	—	—	44,336
2025-04-01	BEAMBeam Therapeutics Inc.S Sale	Director, CEO	SSale	−30.7K sh	$18.35	−$563K	986,249
2025-03-31	BEAMBeam Therapeutics Inc.A Award	Director, CEO	AAward	+77.5K sh	—	—	1,016,159
2025-01-31	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award	Director, CEO	AAward	+155K sh	—	—	155,000
2025-01-30	BEAMBeam Therapeutics Inc.S Sale	Director, CEO	SSale	−29.8K sh	$26.75	−$797K	908,859
2025-01-30	BEAMBeam Therapeutics Inc.S Sale	Director, CEO	SSale	−200 sh	$27.28	−$5,456	908,659
2025-01-30	BEAMBeam Therapeutics Inc.M Exercise/Conversion	Director, CEO	MExercise/Conversion	+30K sh	$0.67	+$20.1K	968,659
2025-01-30	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, CEO	MExercise/Conversion	−30K sh	—	—	69,336
2024-09-30	BEAMBeam Therapeutics Inc.S Sale	Director, CEO	SSale	−60K sh	$24.60	−$1.48M	938,659
2024-06-27	BEAMBeam Therapeutics Inc.S Sale	Director, CEO	SSale	−60K sh	$24.50	−$1.47M	998,343

Recent filings

Accepted (ET)
Oct 164
Evans John M.0001193125-26-424421
SEC(opens sec.gov)
Jul 14
Evans John M.0001193125-26-292526
SEC(opens sec.gov)
Apr 64
Evans John M.0001193125-26-144086
SEC(opens sec.gov)
Apr 14
Evans John M.0001193125-26-138348
SEC(opens sec.gov)

Companies

Address

C/O BEAM THERAPEUTICS INC., 238 MAIN STREET

CAMBRIDGE, MA, 02142